Liquidia Corp

NASDAQ:LQDA   3:59:55 PM EDT
3.96
-0.17 (-4.12%)
Products

Liquidia Corp Says FDA Grants Tentative Approval For Co's Yutrepia(Treprostinil) Inhalation Powder

Published: 11/08/2021 10:54 GMT
Liquidia Corp (LQDA) - FDA Grants Tentative Approval for Liquidia’s Yutrepia™ (treprostinil) Inhalation Powder.
Final FDA Approval May Occur in October 2022 Or Earlier Upon Resolution of On-going Litigation.
Tentative Approval Indicates That Yutrepia Has Met All Regulatory Standards for Quality, Safety, Efficacy Required for Approval in U.S.